These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33374775)

  • 1. PD-L1 Multiplex and Quantitative Image Analysis for Molecular Diagnostics.
    Abdullahi Sidi F; Bingham V; Craig SG; McQuaid S; James J; Humphries MP; Salto-Tellez M
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of multiplex immunofluorescence and digital image analysis for programmed death-ligand 1 expression and immune cell assessment in non-small cell lung cancer: comparison with conventional immunohistochemistry.
    Wu J; Mao L; Sun W; Yang X; Wang H; Liu X; Chi K; Huang X; Lin D
    J Clin Pathol; 2022 Jul; 75(7):452-458. PubMed ID: 33782193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study.
    Taube JM; Roman K; Engle EL; Wang C; Ballesteros-Merino C; Jensen SM; McGuire J; Jiang M; Coltharp C; Remeniuk B; Wistuba I; Locke D; Parra ER; Fox BA; Rimm DL; Hoyt C
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the Diagnostic Accuracy of the PD-L1 Test with Image Analysis and Multiplex Hybridization.
    Humphries MP; Bingham V; Abdullahi Sidi F; Craig SG; McQuaid S; James J; Salto-Tellez M
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visible- and near-infrared hyperspectral imaging for the quantitative analysis of PD-L1+ cells in human lymphomas: Comparison with fluorescent multiplex immunohistochemistry.
    Brunner A; Willenbacher E; Willenbacher W; Zelger B; Zelger P; Huck CW; Pallua JD
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121940. PubMed ID: 36208576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma.
    Yaseen Z; Gide TN; Conway JW; Potter AJ; Quek C; Hong AM; Long GV; Scolyer RA; Wilmott JS
    Front Mol Biosci; 2022; 9():810858. PubMed ID: 35664673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a multiplex immuno-oncology biomarker and digital pathology workflow for assessment of urothelial carcinoma.
    Xie Y; Olkhov-Mitsel E; Alminawi S; Slodkowska E; Downes MR
    Pathol Res Pract; 2021 Oct; 226():153607. PubMed ID: 34509050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital image analysis in pathologist-selected regions of interest predicts survival more accurately than whole-slide analysis: a direct comparison study in 153 gastric carcinomas.
    Heo YJ; Lee T; Byeon SJ; Kim EJ; Shin HC; Kim B; Kang SY; Ha SY; Kim KM
    J Pathol Clin Res; 2021 Jan; 7(1):42-51. PubMed ID: 32885920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital Image Analysis for Estimating Stromal CD8+ Tumor-Infiltrating Lymphocytes in Lung Adenocarcinoma.
    Jhun I; Shepherd D; Hung YP; Madrigal E; Le LP; Mino-Kenudson M
    J Pathol Inform; 2021; 12():28. PubMed ID: 34447608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical Appraisal of Programmed Death Ligand 1 Reflex Diagnostic Testing: Current Standards and Future Opportunities.
    Humphries MP; McQuaid S; Craig SG; Bingham V; Maxwell P; Maurya M; McLean F; Sampson J; Higgins P; Greene C; James J; Salto-Tellez M
    J Thorac Oncol; 2019 Jan; 14(1):45-53. PubMed ID: 30296485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment.
    Viratham Pulsawatdi A; Craig SG; Bingham V; McCombe K; Humphries MP; Senevirathne S; Richman SD; Quirke P; Campo L; Domingo E; Maughan TS; James JA; Salto-Tellez M
    Mol Oncol; 2020 Oct; 14(10):2384-2402. PubMed ID: 32671911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
    McLaughlin J; Han G; Schalper KA; Carvajal-Hausdorf D; Pelekanou V; Rehman J; Velcheti V; Herbst R; LoRusso P; Rimm DL
    JAMA Oncol; 2016 Jan; 2(1):46-54. PubMed ID: 26562159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an automated combined positive score prediction pipeline using artificial intelligence on multiplexed immunofluorescence images.
    Vahadane A; Sharma S; Mandal D; Dabbeeru M; Jakthong J; Garcia-Guzman M; Majumdar S; Lee CW
    Comput Biol Med; 2023 Jan; 152():106337. PubMed ID: 36502695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.
    Mori H; Bolen J; Schuetter L; Massion P; Hoyt CC; VandenBerg S; Esserman L; Borowsky AD; Campbell MJ
    J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):417-432. PubMed ID: 33590360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
    Mercier A; Conan-Charlet V; Quintin-Roué I; Doucet L; Marcorelles P; Uguen A
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use.
    Shafi S; Kellough DA; Lujan G; Satturwar S; Parwani AV; Li Z
    J Pathol Inform; 2022; 13():100122. PubMed ID: 36268080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
    Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
    Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue.
    Parra ER; Ferrufino-Schmidt MC; Tamegnon A; Zhang J; Solis L; Jiang M; Ibarguen H; Haymaker C; Lee JJ; Bernatchez C; Wistuba II
    Sci Rep; 2021 Apr; 11(1):8511. PubMed ID: 33875760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.
    Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
    Histopathology; 2019 May; 74(6):917-924. PubMed ID: 30585668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DAB-quant: An open-source digital system for quantifying immunohistochemical staining with 3,3'-diaminobenzidine (DAB).
    Patel S; Fridovich-Keil S; Rasmussen SA; Fridovich-Keil JL
    PLoS One; 2022; 17(7):e0271593. PubMed ID: 35857792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.